Mind Medicine (MindMed) Inc. Common Shares
MNMD CA60255C8850
Mind Medicine Inc., doing business as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
-66% | -90% | 47% | 92% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Karlin Daniel SR OFF |
9.77 USD |
7,704 Sold |
75,268 USD |
25/09/2025 | 25/09/2025 |
Sullivan Mark CLO |
9.77 USD |
11,278 Sold |
110,186 USD |
25/09/2025 | 25/09/2025 |
Barrow Robert CEO |
9.77 USD |
25,797 Sold |
252,037 USD |
25/09/2025 | 25/09/2025 |
Karlin Daniel CMO |
6.80 USD |
7,848 Sold |
53,366 USD |
25/06/2025 | 25/06/2025 |
Sullivan Mark CLO |
6.80 USD |
11,491 Sold |
78,139 USD |
25/06/2025 | 25/06/2025 |
Karlin Daniel CMO |
6.80 USD |
7,848 Sold |
53,366 USD |
25/06/2025 | 25/06/2025 |
Sullivan Mark CLO |
6.80 USD |
11,491 Sold |
78,139 USD |
25/06/2025 | 25/06/2025 |
Barrow Robert CEO |
6.80 USD |
26,491 Sold |
180,139 USD |
25/06/2025 | 25/06/2025 |
Barrow Robert CEO |
6.80 USD |
26,491 Sold |
180,139 USD |
25/06/2025 | 25/06/2025 |
Liao Carrie CCO |
6.74 USD |
2,347 Sold |
15,819 USD |
25/03/2025 | 25/03/2025 |